{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Overexpression of mutant A53T α-synuclein enhances LC3-I conversion into LC3-II and decreases the levels of p62 (paired t test).",
          "judgment": "Yes",
          "reasoning": "The paper indicates that the mutant A53T α-synuclein affects autophagy-related processes (LC3 conversion and p62 levels), which are relevant to the disease mechanism being studied."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "t test and one-way ANOVA, followed by a Newman-Keuls posthoc test or Kruskal-Wallis test, followed by a Dunn's test were then used to compare the differences between the samples and the control group. A two-way ANOVA was used to analyze the interaction between treatments.",
          "judgment": "Yes",
          "reasoning": "The paper utilizes statistical tests commonly applied in similar studies to assess functional effects, making the general class of assays applicable.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The counting analyses (colocalization, mitochondrial density, and toxicity analyses) were performed in a blinded manner.",
          "judgment": "Yes",
          "reasoning": "The paper mentions that analyses were performed in a blinded manner, suggesting that controls were included. However, it does not explicitly state that both wild-type and null controls were used, nor does it specify the number of replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Cortical neurons were cotransfected with mutant A53T α-synuclein, EGFP-LC3 as the autophagosome marker, and mitochondrial markers.",
          "judgment": "No",
          "reasoning": "The paper does not mention the use of known pathogenic or benign variant controls in the assay for this variant. The focus is on the mutant A53T variant itself in relation to autophagy markers.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper reports that overexpression of mutant A53T α-synuclein enhances LC3-I conversion into LC3-II and decreases the levels of p62 using paired t test.",
          "judgment": "N/A",
          "reasoning": "The paper does not provide a count of total benign/pathogenic variant controls used across the study. The focus is on the A53T variant without comparison to other controls.",
          "next_step_or_outcome": "Proceed to Step 4b"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence supports a pathogenic role for the SNCA A53T variant based on its effect on autophagy markers (LC3 and p62). However, the evidence is limited to supporting strength due to insufficient controls and lack of OddsPath calculation."
    }
  ]
}